Robot-assisted treatment of XXXX .

@entity1 @entity190 @entity397 @entity439 @entity5475 @entity438
BACKGROUND: Although @entity438 ( @entity438 ) are relatively uncommon, they are clinically relevant because of the risk of @entity397 . Optimal management is a matter of debate and involves the use of percutaneous endovascular stenting, which has limitations, versus the  open surgical approach which can lead to significant morbidity. The present study reports the outcomes of robot-assisted surgery for @entity5475 and its role in overcoming many of the limitations of laparoscopy. METHODS: A total of nine @entity1 with incidentally detected @entity438 underwent a surgery between September 2001 and November 2007. Six of these nine @entity1 underwent a robot-assisted @entity439 resection with vascular reconstruction. The remaining three cases included one robotic arterial ligation, one robotic partial splenectomy, and one laparoscopic splenectomy. RESULTS: The mean operating time was 212    61 minutes (range: 90-300), mean intraoperative @entity190 was 186.6    202.4 mL (range: 0-500), and mean hospital stay was 7.1    3.7 days (range: 3-14). The morbidity rate was 11.1% and no mortality was reported. Doppler-ultrasonography surveillance showed regular organ perfusion in all @entity1 with vascular reconstruction. CONCLUSION: Robot-assisted surgery for @entity5475 represents one of the most advanced developments among minimally invasive procedures and can become an important option for the treatment of this disease.
